PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
23.23%
Some net income increase while CRK is negative at -303.50%. John Neff would see a short-term edge over the struggling competitor.
-10.66%
Negative yoy D&A while CRK is 165.33%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
36.21%
Well above CRK's 57.13% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
-350.00%
Both cut yoy SBC, with CRK at -0.53%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
-9.09%
Negative yoy working capital usage while CRK is 89.71%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-9.09%
Negative yoy usage while CRK is 75.01%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-151.72%
Both negative yoy, with CRK at -412.51%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
52.01%
Operating cash flow growth at 50-75% of CRK's 97.92%. Martin Whitman would worry about lagging operational liquidity vs. competitor.
36.34%
CapEx growth well above CRK's 36.64%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-29.29%
Negative yoy acquisition while CRK stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-40.50%
Negative yoy purchasing while CRK stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-36.34%
We reduce yoy sales while CRK is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
32.43%
Growth of 32.43% while CRK is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
20.12%
Lower net investing outflow yoy vs. CRK's 219.21%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
98.86%
We repay more while CRK is negative at -1460.65%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.